Biotech News

Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement

Acadia Healthcare (ACHC)Acadia HealthcareFDA / regulatory

FRANKLIN, Tenn. --(BUSINESS WIRE)--Sep. 25, 2026-- Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) issues the below summary notice of proposed settlement as provided for in the September 1, 2026 order providing preliminary approval issued by the United States District

Related news

HYPRHyperfine2026-11-03 21:05 EST

Hyperfine to Participate in Jefferies London and BTIG Tech-Enabled Healthcare Conferences

ACHCAcadia Healthcare2026-11-04 21:05 EST

Acadia Healthcare Announces Third Quarter 2026 Results and Raises Full Year 2026 Financial Guidance

ACHCAcadia Healthcare2026-11-02 21:30 EST

Acadia Healthcare to Participate in November Investor Conferences

ICUSeaStar Medical2026-11-03 13:21 EST

FDA Confirms SeaStar Medical Has Fulfilled the Post-Approval Study Requirements for QUELIMMUNE® for the Treatment of Sepsis-Associated Acute Kidney Injury (AKI) in Pediatric Patients

DNLIDenali Therapeutics2026-10-30 13:30 EST

Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product

IRTCiRhythm2026-11-11 21:05 EST

iRhythm Announces Approval of $200 Million Share Repurchase Program

JNJJohnson & Johnson2026-10-23 11:09 EST

European Commission approves Johnson & Johnson’s TECVAYLI®▼ (teclistamab) monotherapy for relapsed/refractory multiple myeloma, expanding treatment options from first relapse

JNJJohnson & Johnson2026-10-16 10:31 EST

CHMP recommends approval of Johnson & Johnson’s TALVEY®▼ (talquetamab) plus daratumumab in earlier line treatment of relapsed/refractory multiple myeloma

ICUSeaStar Medical2026-10-07 12:16 EST

FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition

VTAKCatheter Precision2026-10-29 20:15 EST

Flyte Aviation Expands International Operations to Canada

Acadia Healthcare

Behavioral Healthcare Network Acadia Healthcare operates facilities that treat mental-health and substance-use disorders. Its network includes acute inpatient psychiatric hospitals, specialty treatment facilities and other behavioral-care settings. Inpatient and Specialty Care The company provides structured treatment for patients who...

Recent company news

Stock data

Close
34.47 USD
Market cap
2.25B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States